FOXP3 and urinary bladder carcinoma: In the present study we demonstrated that the Foxp3 can enhance HIF-1α protein expression through decreasing ubiquitin-mediated proteasomal degradation in bladder cancer cells and influences VEGF signaling and intratumoral immunity, contributing an unfavorable prognosis in bladder cancer.